Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Debt Ratio (2017 - 2023)

Sutro Biopharma's Debt Ratio history spans 7 years, with the latest figure at 0.01 for Q4 2023.

  • For Q4 2023, Debt Ratio fell 78.42% year-over-year to 0.01; the TTM value through Dec 2023 reached 0.01, down 78.42%, while the annual FY2023 figure was 0.01, 78.42% down from the prior year.
  • Debt Ratio for Q4 2023 was 0.01 at Sutro Biopharma, down from 0.02 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.16 in Q1 2020 and bottomed at 0.01 in Q4 2023.
  • The 5-year median for Debt Ratio is 0.07 (2019), against an average of 0.06.
  • The largest annual shift saw Debt Ratio surged 122.78% in 2020 before it crashed 78.42% in 2023.
  • A 5-year view of Debt Ratio shows it stood at 0.06 in 2019, then fell by 1.39% to 0.06 in 2020, then rose by 18.11% to 0.07 in 2021, then plummeted by 45.64% to 0.04 in 2022, then crashed by 78.42% to 0.01 in 2023.
  • Per Business Quant, the three most recent readings for STRO's Debt Ratio are 0.01 (Q4 2023), 0.02 (Q3 2023), and 0.02 (Q2 2023).